|
|
|
Feed Submission If you'd like OHCNetwork Health News to link to your health news or blog from this category (Cystic Fibrosis - Diseases and Conditions), please submit your RSS or XML feed to OHCNetwork Health News. Contact information is available here. |
Health News >> Diseases and Conditions >> Cystic Fibrosis
Cystic Fibrosis News
Cystic Fibrosis News From Medical News Today
Axentis Pharma AG has initiated a clinical phase IIa trial to assess the safety and tolerability of a new therapeutic formulation for the treatment of severe pulmonary infection in cystic fibrosis patients. The new formulation allows an established therapeutic agent to be delivered directly to the site of infection. The forthcoming trial will also compare the effects of two different doses of the new drug. Initial results are expected in summer 2009.
Cystic Fibrosis News From Medical News Today
Pharmaceutical company Pharmaxis (ASX: PXS; Nasdaq: PXSL) announced that it has enrolled the first subject into its second pivotal Phase 3 clinical trial evaluating Bronchitol in cystic fibrosis sufferers. The Phase 3 trial is being conducted in 41 hospitals across North America, Argentina and Germany, and is the final clinical step before Pharmaxis seeks approval to market Bronchitol for cystic fibrosis in the United States.
Cystic Fibrosis News From Medical News Today
Axentis Pharma AG has initiated a clinical phase IIa trial to assess the safety and tolerability of a new therapeutic formulation for the treatment of severe pulmonary infection in cystic fibrosis patients. The new formulation allows an established therapeutic agent to be delivered directly to the site of infection. The forthcoming trial will also compare the effects of two different doses of the new drug. Initial results are expected in summer 2009.
Cystic Fibrosis News From Medical News Today
Kamada (TASE: KMDA), a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced that it has completed a Phase II Study with Aerosolized Alpha-1 Antitrypsin (AAT), delivered via an optimized eFlow platform nebulizer (PARI Pharma GmbH), in cystic fibrosis (CF).
Cystic Fibrosis News From Medical News Today
Chemical engineers from Johns Hopkins University have broken the "mucus barrier," engineering the first drug-delivery particles capable of passing through human mucus - regarded by many as nearly impenetrable - and carrying medication that could treat a range of diseases. Those conditions include lung cancer, cervical cancer and cystic fibrosis, the research noted in a presentation scheduled for the 236th National Meeting of the American Chemical Society.
Cystic Fibrosis News From Medical News Today
Researchers in Israel have found that a new drug for cystic fibrosis, PTC124, is able to bypass the genetic defect in the protein-making machinery of patients and improve the functioning of weakened cell membranes. The results in published in an upcoming edition of The Lancet.
Cystic Fibrosis News From Medical News Today
New phase 2 data published today in The Lancet show that the investigational oral drug PTC124 demonstrates activity in nonsense-mutation cystic fibrosis (CF). The data show that treatment with PTC124 results in statistically significant improvements in the chloride channel function of patients with nonsense-mutation CF.
Cystic Fibrosis News From Medical News Today
Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced modifications to the clinical protocol for TIGER-2, the Company's ongoing second Phase 3 trial with denufosol tetrasodium for the treatment of cystic fibrosis (CF). "The availability of the extensive data set from the positive TIGER-1 trial provides an excellent opportunity to optimize the TIGER-2 trial design," stated Christy L. Shaffer, Ph.D., President and CEO of Inspire.
Cystic Fibrosis News From Medical News Today
A London, Canada scientist studying cystic fibrosis (CF) has successfully corrected the defect which causes the overproduction of intestinal mucous in mice. This discovery by Dr. Richard Rozmahel, a scientist with the Lawson Health Research Institute, affiliated with The University of Western Ontario, has clear implications to understanding and treating this facet of the disease in humans.
Cystic Fibrosis News From Medical News Today
The majority of general internists and pediatricians in the United States are not comfortable serving as primary care providers for young adults with complex chronic illnesses that originate during childhood, according to findings from a new national survey.
Cystic Fibrosis News From Medical News Today
Researchers in Japan and Canada have discovered a key component of the quality control mechanism that operates inside human cells - sometimes too well. The breakthrough has significant implications for the development of new treatments for cystic fibrosis (CF) and some other hereditary diseases, the researchers say. Their results were published July 25 in the journal Science. Dr.
Cystic Fibrosis News From Medical News Today
The U.S. House of Representatives passed a resolution to encourage public awareness and understanding of cystic fibrosis, and support research to find a cure for the disease. The Cystic Fibrosis Foundation applauds the House for this important achievement. Introduced by co-chairs of the Congressional Cystic Fibrosis Caucus, Representatives Ed Markey (D-Mass.) and Cliff Stearns (R-Fl.
Cystic Fibrosis News From Medical News Today
Four states-- Arkansas, Kansas, Maine, and West Virginia--have joined 40 others and the District of Columbia in requiring that all newborns be screened for cystic fibrosis (CF) at birth. In addition, Utah has cleared the way to begin regular CF screening as well. Routine screening is expected to begin January 1, 2009.
Cystic Fibrosis News From Medical News Today
FoldRx Pharmaceuticals, Inc. (FoldRx) announced that it has discovered a series of novel drug prototypes that have shown potential in vitro to correct the protein-folding defect associated with cystic fibrosis (CF). The discovery, made through a research collaboration announced last year with Cystic Fibrosis Foundation Therapeutics, Inc.
Cystic Fibrosis News From Medical News Today
Amazingly, surfers have unknowingly held a key to prolonging the lifespan and quality of life for people with cystic fibrosis (CF), a fatal genetic disease that causes the body to produce thick, sticky mucus, which clogs the lungs and leads to life-threatening lung infections. Several years ago, doctors in Australia noticed young surfers with cystic fibrosis had significantly healthier lungs.
Cystic Fibrosis News From Medical News Today
Aradigm Corporation (OTCBB:ARDM) (the "Company") announced positive results from an open-label, two week efficacy and safety study of its once daily inhaled liposomal ciprofloxacin in patients with cystic fibrosis (CF). The study conducted at leading CF centers in Australia and New Zealand enrolled a total of 22 patients.
Cystic Fibrosis News From Medical News Today
Mpex Pharmaceuticals, Inc. announced that it has initiated a Phase 2 clinical study with MP-376 for the treatment of pulmonary infections due to Pseudomonas aeruginosa and other bacteria in patients with cystic fibrosis. MP-376 is Mpex's proprietary aerosol formulation of levofloxacin, an antibiotic that has potent activity against key bacterial pathogens, including Pseudomonas aeruginosa.
Cystic Fibrosis News From Medical News Today
At the 31st European Cystic Fibrosis Society (ECFS) Annual Meeting in Prague, Czech Republic, researchers presented interim results from the first clinical trial of the investigational oral agent VX-770 in cystic fibrosis patients.
Cystic Fibrosis News From Medical News Today
Transave, Inc., reported positive results from a Phase II clinical trial on its lead investigational drug, Arikace(TM) (liposomal amikacin for inhalation). The compound is being developed for the treatment of cystic fibrosis (CF) patients who have lung infections due to the bacterium Pseudomonas aeruginosa.
Cystic Fibrosis News From Medical News Today
PTC Therapeutics, Inc. (PTC) announced promising new data from two studies of PTC124 in cystic fibrosis (CF).
Cystic Fibrosis News From Medical News Today
Alabama has joined 39 other states and the District of Columbia in requiring that all newborns be screened for cystic fibrosis at birth. "We congratulate Alabama for initiating a newborn screening program for cystic fibrosis," said Robert J. Beall, Ph.D., president and CEO of the Cystic Fibrosis Foundation. "More than 40 states are now screening for the disease.
Cystic Fibrosis News From Medical News Today
The 13th annual Breathing Life Awards will be taking place on Wednesday 28th May at Hilton Metropole and televised on Sky Real Lives (Sky channel 253) on Sunday 1st June, 9.30pm. Hosted by Carol Smillie and Dr David Bull, the glitzy awards ceremony celebrates the outstanding achievement of inspiring people that have Cystic Fibrosis (CF), the UK's most common life-threatening inherited disease.
Cystic Fibrosis News From Medical News Today
Scientists from the UK CF Gene Therapy Consortium funded by the Cystic Fibrosis Trust have overcome a major obstacle in their ground-breaking gene therapy programme for Cystic Fibrosis. Cystic Fibrosis (CF) is the UK's most common life-threatening inherited disease and is caused by a single defective gene.
Cystic Fibrosis News From Medical News Today
The Alabama Department of Public Health in partnership with the cystic fibrosis centers at the University of Alabama at Birmingham, Children's Hospital of Alabama and the University of South Alabama announces further significant expansion of Alabama's newborn screening program. On April 21, Alabama will add cystic fibrosis to its panel of primary newborn screening tests.
Cystic Fibrosis News From Medical News Today
During the Satellite Symposium 3: The Challenges of Lung Transplantation in Cystic Fibrosis (CF) at the International Society of Heart and Lung Transplantation (ISHLT) Annual Meeting & Scientific Sessions, clinicians and researchers discussed some of the unique challenges in achieving excellent lung transplant outcomes in patients with CF.
| ||||||||||||||||||
| ||||||||||||||||||